Efficacy of therapy for advanced hepatocellular carcinoma: Intra-arterial 5-fluorouracil and subcutaneous interferon with image-guided radiation

Journal of Gastroenterology and Hepatology (Australia)

Volumn 26, Issue 7, 2011, Pages 1123-1132

  Chuma, Makoto ^a   Taguchi, Hiroshi ^a   Yamamoto, Yoshiya ^b   Shimizu, Shinichi ^a   Nakanishi, Mitsuru ^a   Ogawa, Koji ^b   Sho, Takuya ^a   Horimoto, Hiromasa ^a   Kobayashi, Tomoe ^a   Nakai, Masato ^a   Terashita, Katsumi ^a   Sakuhara, Yusuke ^a   Abo, Daisuke ^a   Tsukuda, Yoko ^a   Tsunematsu, Seiji ^a   Hige, Shuhei ^a   Kato, Mototsugu ^a   Shirato, Hiroki ^a   Asaka, Masahiro ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b Hakodate Municipal Hospital   (Japan)

Author keywords

5 fluorouracil; Hepatocellular carcinoma; Image guided radiation therapy; Interferon; Portal vein tumor thrombosis

Indexed keywords

ALPHA INTERFERON; FLUOROURACIL; PEGINTERFERON ALPHA2B;

ADVANCED CANCER; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FEVER; HUMAN; LEUKOPENIA; LIVER CELL CARCINOMA; MALE; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; RADIATION DOSE; THROMBOCYTOPENIA; TREATMENT DURATION; TREATMENT RESPONSE;

EID: 79958847780     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2011.06745.x     Document Type: Article

References (31)

1. Kiyosawa K, Umemura T, Ichijo T etal. Hepatocellular carcinoma: recent trends in Japan. Gastroenterology 2004; 127: S17-26.
2. Llovet JM, Bustamante J, Castells A etal. Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials. Hepatology 1999; 29: 62-7.
3. Yeung YP, Lo CM, Liu CL etal. Natural history of untreated nonsurgical hepatocellular carcinoma. Am. J. Gastroenterol. 2005; 100: 1995-2004.
4. Lee HS, Kim JS, Choi IJ etal. The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction. A prospective controlled study. Cancer 1997; 79: 2087-94.
5. Uka K, Aikata H, Takaki S etal. Similar effects of recombinant interferon-alpha-2b and natural interferon-alpha when combined with intra-arterial 5-fluorouracil for the treatment of advanced hepatocellular carcinoma. Liver Int. 2007; 27: 1209-16.
6. Sakon M, Nagano H, Dono K etal. Combined intra-arterial 5-fluorouracil and subcutaneous interferon-alpha therapy for advanced hepatocellular carcinoma with tumor thrombi in the major portal branches. Cancer 2002; 94: 435-42.
7. Ota H, Nagano H, Sakon M etal. Treatment of hepatocellular carcinoma with major portal vein thrombosis by combined therapy with subcutaneous interferon-α and intra-arterial 5-fluorouracil: role of type I interferon receptor expression. Br. J. Cancer 2005; 93: 557-64.
8. Obi S, Yoshida H, Toune R etal. Combination therapy of intraarterial 5-fluorouracil and systemic interferon-alpha for advanced hepatocellular carcinoma with portal venous invasion. Cancer 2006; 106: 1990-7.
9. Kasai K, Kuroda H, Ushio A etal. Evaluation of newly developed combination therapy of intra-arterial 5-fluorouracil and systemic pegylated interferon alpha-2b for advanced hepatocellular carcinoma with portal venous invasion: preliminary results. Hepatol. Res. 2009; 39: 117-25.
10. Han KH, Seong J, Kim JK etal. Pilot clinical trial of localized concurrent chemoradiation therapy for locally advanced hepatocellular carcinoma with portal vein thrombosis. Cancer 2008; 113: 995-1003.
11. Kim DY, Park W, Lim DH etal. Three-dimensional conformal radiotherapy for portal vein thrombosis of hepatocellular carcinoma. Cancer 2005; 103: 2419-26.
12. Toya R, Murakami R, Baba Y etal. Conformal radiation therapy for portal vein tumor thrombosis of hepatocellular carcinoma. Radiother. Oncol. 2007; 84: 266-71.
13. Shirato H, Shimizu S, Shimizu T etal. Real-time tumortracking radiotherapy. Lancet 1999; 353: 1331-2.
14. Katoh N, Onimaru R, Sakuhara Y etal. Real-time tumor-tracking radiotherapy for adrenal tumors. Radiother. Oncol. 2008; 87: 418-24.
15. Harada T, Shirato H, Ogura S etal. Real-time tumor-tracking radiation therapy for lung carcinoma by the aid of insertion of a gold marker using bronchofiberscopy. Cancer 2002; 95: 1720-7.
16. Taguchi H, Sakuhara Y, Hige S etal. Intercepting radiotherapy using a real-time tumor-tracking radiotherapy system for highly selected patients with hepatocellular carcinoma unresectable with other modalities. Int. J. Radiat. Oncol. Biol. Phys. 2007; 69: 376-80.
17. Guckenberger M, Sweeney RA, Wilbert J etal. Image-guided radiotherapy for liver cancer using respiratory-correlated computed tomography and cone-beam computed tomography. Int. J. Radiat. Oncol. Biol. Phys. 2008; 71: 297-304.
18. Fuss M, Salter BJ, Herman TS etal. External beam radiation therapy for hepatocellular carcinoma: potential of intensity-modulated and image-guided radiation therapy. Gastroenterology 2004; 127: S206-17.
19. Hawkins MA, Dawson LA. Radiation therapy for hepatocellular carcinoma: from palliation to cure. Cancer 2006; 106: 1653-63.
20. Bruix J, Sherman M; Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology 2005; 42: 1208-36.
21. Ando E, Yamashita F, Tanaka M etal. A novel chemotherapy for advanced hepatocellular carcinoma with tumor thrombosis of the main trunk of the portal vein. Cancer 1997; 79: 1890-6.
22. Oken MM, Creech RH, Tormey DC etal. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am. J. Clin. Oncol. 1982; 5: 649-55.
23. Therasse P, Arbuck SG, Eisenhauer EA etal. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J. Natl. Cancer Inst. 2000; 92: 205-16.
24. Lawrence TS, Robertson JM, Anscher MS etal. Hepatic toxicity resulting from cancer treatment. Int. J. Radiat. Oncol. Biol. Phys. 1995; 31: 1237-48.
25. Wadler S, Schwartz EL. Antineoplastic activity of the combination of interferon and cytotoxic agents against experimental and human malignancies: a review. Cancer Res. 1990; 50: 3473-86.
26. Miyamoto A, Umeshita K, Sakon M etal. Advanced hepatocellular carcinoma with distant metastases, successfully treated by a combination therapy of a-interferon and oral tegafur/uracil. J. Gastroenterol. Hepatol. 2000; 15: 1447-51.
27. Katamura Y, Aikata H, Takaki S etal. Intra-arterial 5-fluorouracil/interferon combination therapy for advanced hepatocellular carcinoma with or without three-dimensional conformal radiotherapy for portal vein tumor thrombosis. J. Gastroenterol. 2009; 44: 492-502.
28. Sazawa A, Shinohara N, Harabayashi T etal. Alternative approach in the treatment of adrenal metastasis with a real-time tracking radiotherapy in patients with hormone refractory prostate cancer. Int. J. Urol. 2009; 16: 410-12.
29. Onimaru R, Shirato H, Aoyama H etal. Calculation of rotational setup error using the real-time tracking radiation therapy (RTRT) system and its application to the treatment of spinal schwannoma. Int. J. Radiat. Oncol. Biol. Phys. 2002; 54: 939-47.
30. Shirato H, Shimizu S, Kitamura K etal. Organ motion in image-guided radiotherapy: lessons from real-time tumor-tracking radiotherapy. Int. J. Clin. Oncol. 2007; 12: 8-16.
31. Chung YL, Jian JJ, Cheng SH etal. Sublethal irradiation induces vascular endothelial growth factor and promotes growth of hepatoma cells: implications for radiotherapy of hepatocellular carcinoma. Clin. Cancer Res. 2006; 12: 2706-15.